KConnor56
01-28-2003, 10:17 PM
Viral load in HCV RNA-positive pregnant women
Paternoster DM, Santarossa C, Grella P, Palu G, Baldo V, Boccagni P,
Floreani A. Department of Obstetrics and Gynecology, Institute of
Hygiene, University of Padua, Italy. Am J Gastroenterol 2001
Sep;96(9):2751-4
OBJECTIVES: The risk of hepatitis C virus (HCV) infection in the
newborn is estimated to be around 5%, but becomes very high in the
case of coinfection with HIV. One of the main factors associated
with the vertical transmission of HCV is the viral load. Our
objective was to investigate the behavior of HCV viral load during
pregnancy in relation to HIV coinfection, liver enzymes, and
vertical transmission. METHODS: Three thousand seven hundred
forty-eight women seen consecutively in their first trimester of
pregnancy were screened for HCV infection. Sixty-five were found to
be anti-HCV+/HCV RNA+ and were followed up with clinical and
serological assessment (i.e., transaminases and quantitative
polymerase chain reaction [PCR] for viral load) in their second and
third trimesters and 6 months after delivery. All were anti-HIV and
hepatitis B surface antigen negative. HCV RNA was 12.0+/-19.9 x
10(6) copies/ml in the first trimester and 10.9+/-13.3 x 10(6) in
the second, but increased to 19.5+/-25.1 x 10(6) in the third
trimester. Six months after delivery the viral load returned to the
baseline levels; the changes in viral load did not reach any
statistical significance, however. Transaminases tended toward a
reduction from the baseline during the second and third trimesters,
and then an increase in both AST and ALT was recorded 6 months after
delivery. However, when the group whose AST/ALT were found abnormal
at the first test was considered, no significant changes were
recorded during the follow-up. The overall rate of vertical
transmission was 4.6 CONCLUSIONS: With HCV+ mothers monitoring
transaminases during pregnancy is unnecessary, and testing liver
enzymes at the beginning of pregnancy is sufficient. Qualitative PCR
should be done once during the pregnancy, but any staging of the
liver disease should be taken after delivery. Quantitative PCR
testing is expensive and pointless. Any decision for elective
cesarean section in HCV RNA+ mothers should be confirmed by other
studies.
http://www.natap.org/
Paternoster DM, Santarossa C, Grella P, Palu G, Baldo V, Boccagni P,
Floreani A. Department of Obstetrics and Gynecology, Institute of
Hygiene, University of Padua, Italy. Am J Gastroenterol 2001
Sep;96(9):2751-4
OBJECTIVES: The risk of hepatitis C virus (HCV) infection in the
newborn is estimated to be around 5%, but becomes very high in the
case of coinfection with HIV. One of the main factors associated
with the vertical transmission of HCV is the viral load. Our
objective was to investigate the behavior of HCV viral load during
pregnancy in relation to HIV coinfection, liver enzymes, and
vertical transmission. METHODS: Three thousand seven hundred
forty-eight women seen consecutively in their first trimester of
pregnancy were screened for HCV infection. Sixty-five were found to
be anti-HCV+/HCV RNA+ and were followed up with clinical and
serological assessment (i.e., transaminases and quantitative
polymerase chain reaction [PCR] for viral load) in their second and
third trimesters and 6 months after delivery. All were anti-HIV and
hepatitis B surface antigen negative. HCV RNA was 12.0+/-19.9 x
10(6) copies/ml in the first trimester and 10.9+/-13.3 x 10(6) in
the second, but increased to 19.5+/-25.1 x 10(6) in the third
trimester. Six months after delivery the viral load returned to the
baseline levels; the changes in viral load did not reach any
statistical significance, however. Transaminases tended toward a
reduction from the baseline during the second and third trimesters,
and then an increase in both AST and ALT was recorded 6 months after
delivery. However, when the group whose AST/ALT were found abnormal
at the first test was considered, no significant changes were
recorded during the follow-up. The overall rate of vertical
transmission was 4.6 CONCLUSIONS: With HCV+ mothers monitoring
transaminases during pregnancy is unnecessary, and testing liver
enzymes at the beginning of pregnancy is sufficient. Qualitative PCR
should be done once during the pregnancy, but any staging of the
liver disease should be taken after delivery. Quantitative PCR
testing is expensive and pointless. Any decision for elective
cesarean section in HCV RNA+ mothers should be confirmed by other
studies.
http://www.natap.org/